We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common challenges you meet with during the
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,
SCOPE 2020 is almost upon us!
This year, ArcheMedX is helping to shape the conversation on how we, as clinical operations leaders, can improve clinical trial readiness. It is our hope to connect with you and your colleagues in Orlando to spark a conversation that explores operational challenges further and helps